Feature Articles

Feature Articles @ITREN in 2018~2023 (최근 5년간 출간된 하이라이트 논문 40편)

Author :
ITREN (2023-09-21)
Views :

※ Feature Articles @ ITREN 2018~2023

최근 5년간 출간된 하이라이트 논문들

40. Adv Sci (2023년)   (IF=15, 상위 2.7%)

“Cyclic stretch promotes cellular reprogramming process through cytoskeletal-nuclear mechao-coupling and epigenetic modification"

39. Adv Funct Mater (2023년)   (IF=19, 상위 1.8%)

“Coordinated biophysical stimulation of MSCs via electromagnetized Au-nanofiber regulates cytoskeletal-to-nuclear mechano-responses"

38. Trends in Biotech (2023년)   (IF=17.3, 상위 2.8%)

“Advanced materials technologies to unravel mechanobiological pheneomena"

37. Bioactive Mater (2023년)   (IF=18.9, 상위 1.5%)

“Double hits with bioactive nanozyme based on cobalt-doped nanoglass for acute and diabetic wound therapies"

36. Prog Mater Sci (2023년)   (IF=48.145, 상위 0.8%)

“Materials-based nanotherapeutics for injured and diseased bone”

35. Mater Today Bio (2023년)   (IF=10.76, 상위 8.8%)

“Multifunctional dendrimer@nanoceria engineered GelMA hydrogel accerates bone regeneration through orchestrated..."

34. Chem Eng J (2023년)   (IF=16.744, 상위 3%)

“Electroconductive and mechano-competent PUCL@CNT nanohybrid scaffolds guiding neural specification”

33. Biomaterials (2023년)   (IF=15.304, 상위 1.7%)

“Mechano-modulation of T cells for cancer immunotherapy"

32. Matter (2022년)   (IF=19.9, 상위 2%)

“Matrix-enabled mechanobiological modulation of osteoimmunology”

21. Biomaterials (2022년) (IF=15.304 , 상위 1.7%)

“Chemically-induced osteogenic cells for bone tissue engineering and disease modeling”

30. Cell Death Diff (2022년) (IF=12.073 , 상위 5.9%)

“TLR4 downregulation by the RNA-binding protein PUM1 alleviates cellular aging and osteoarthritis”

29. Trend Mol Med (2022년) (IF=15.272 , 상위 4.7 %)

“Leveraging cellular mechano-responsiveness for cancer therapy”

28. Adv Health Mater (2022년) (IF=11.092 , 상위 8%)

“Delivery of Induced Neural Stem Cells Through Mechano-tuned Silk-collagen Hydrogels for the Recovery of Contused Spinal Cord in Rats”

27. Biomaterials (2022년) (IF=15.304 , 상위 1.7%)

“Nanoceria-GO-intercalated multicellular spheroids revascularize and salvage critical ischemic limbs through anti-apoptotic and pro-angiogenic functions”

26. Bioactive Mater (2022년) (IF=16.874 , 상위 2%)

“Dendritic cell-mimicking scaffolds for ex vivo T cell expansion”

25. Biomaterials (2022년) (IF=15.304 , 상위 1.7%)

“Diabetic bone regeneration with nanoceria-tailored scaffolds by recapitulating cellular microenvironment: Activating integrin/TGF-β co-signaling of MSCs while relieving oxidative stress”

24. Bioactive Mater (2022년) (IF=16.874 , 상위 2%)

“Materials and extracellular matrix rigidity highlighted in tissue damages and diseases: Implication for biomaterials design and therapeutic targets”

23. Adv Health Mater (2022년) (IF=11.092 , 상위 8%)

“Mimicking Bone Extracellular Matrix: From BMP-2-Derived Sequences to Osteogenic-Multifunctional Coatings”

22. Bioeng. Trans. Med. (2022년) (IF=10.684 , 상위 11%)

“Hyperelastic, shape-memorable, and ultra-cell-adhesive degradable polycaprolactone-polyurethane copolymer for tissue regeneration”

21. Bioactive Mater (2022년) (IF=16.874 , 상위 2%)

“Multifunctional GelMA platforms with nanomaterials for advanced tissue therapeutics”

20. Science Adv. (2021년) (IF=14.980 , 상위 5%)

“Scaffold-mediated CRISPR-Cas9 delivery system for acute myeloid leukemia therapy”

19. Biomaterials (2021년) (IF=15.304 , 상위 1.7%)

“Dual actions of osteoclastic-inhibition and osteogenic-stimulation through strontium-releasing bioactive nanoscale cement imply biomaterial-enabled osteoporosis therapy”

18. Signal Trans Target Therapy (2021년)  (IF=38.120 , 상위 1.3%)

“Spatiotemporal control of CRISPR/Cas9 gene editing”

17. Biomaterials (2021년) (IF=15.304 , 상위 1.7%)

“Electricity auto-generating skin patch promotes wound healing process by activation of mechanosensitive ion channels”

16. Biomaterials (2021년) (IF=15.304 , 상위 1.7%)

“Therapeutic tissue regenerative nanohybrids self-assembled from bioactive inorganic core / chitosan shell nanounits”

15. J. Hepatology (2021년) (IF=30.083 , 상위 2.9%)

“Dysregulation of the ESRP2-NF2-YAP/TAZ axis promotes hepatobiliary carcinogenesis in non-alcoholic fatty liver disease”

14. Chem. Eng. J. (2021년) (IF=16.744 , 상위 3%)

“Optimally dosed nanoceria attenuates osteoarthritic degeneration of joint cartilage and subchondral bone”

13. Biomaterials (2021년) (IF=15.304 , 상위 1.7%)

Antibacterial, proangiogenic, and osteopromotive nanoglass paste coordinates regenerative process following bacterial infection in hard tissue

12. Prog. Mater. Sci. (2020년) (IF=48.165 , 상위 0.8%)

Materials roles for promoting angiogenesis in tissue regeneration

11. Biomaterials (2020년) (IF=15.304 , 상위 1.7%)

Protein-reactive nanofibrils decorated with cartilage-derived decellularized extracellular matrix for osteochondral defects

10. Adv. Funct. Mater. (2020년) (IF=19.924 , 상위 5.5%)

“Molecularly Imprinted Polymers and Electrospinning: Manufacturing Convergence for Next-Level Applications”

9. J. Clinical Investigation (2020년) (IF=19.477 , 상위 1.4%)

“Epithelial splicing regulatory protein 2–mediated alternative splicing reprograms hepatocytes in severe alcoholic hepatitis”

8. Biomaterials (2020년) (IF=15.304 , 상위 4%)

“Revascularization and limb salvage following critical limb ischemia by nanoceria-induced Ref-1/APE1-dependent angiogenesis”

7. Biomaterials (2020년) (IF=15.304 , 상위 1.7%)

“Hierarchical microchanneled scaffolds modulate multiple tissue-regenerative processes of immune-responses, angiogenesis, and stem cell homing”

6. Biomaterials (2019년) (IF=15.304 , 상위 1.7%)

“Anti-inflammatory action of folate-functionalized bioactive ion-releasing nanoparticle imply drug-free nanotherapy of inflamed tissue”

5. PNAS (2019년) (IF=12.779/ 상위 7.4%)

“Implantable multireservoir device with stimulus-responsive membrane for on-demand and pulsatile delivery of growth hormone”

4. Mater Horizons (2019년) (IF= 15.717 / 상위 5.7%)

“Carbon based-nanomaterials as an emerging platform for theranostics”

3. Biomaterials (2019년) (IF=15.304 / 상위 1.7%)

“Role of nuclear mechanosensitivity in determining cellular responses to forces and biomaterials”

2. Adv Drug Deliv Rev (2019년) (IF=17.873 / 상위 1.4%)

“Advanced drug delivery systems and artificial skin grafts for skin wound healing”

1. Biomaterials (2018년) (IF=15.304 / 상위 1.7%)

“Nanocements produced from mesoporous bioactive glass nanoparticles.”